000 01208 a2200361 4500
005 20250513135541.0
264 0 _c19980409
008 199804s 0 0 spa d
022 _a0004-0614
040 _aNLM
_beng
_cNLM
100 1 _aEsteban Fuertes, M
245 0 0 _a[Doxazosin treatment of disorders of the voiding phase in benign prostatic hyperplasia].
_h[electronic resource]
260 _bArchivos espanoles de urologia
_cDec 1997
300 _a1057-66 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article
650 0 4 _aAdrenergic alpha-Antagonists
_xtherapeutic use
650 0 4 _aAged
650 0 4 _aDoxazosin
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMuscle Contraction
650 0 4 _aProspective Studies
650 0 4 _aProstatic Hyperplasia
_xcomplications
650 0 4 _aUrethral Obstruction
_xdrug therapy
700 1 _aSalinas Casado, J
700 1 _aVirseda Chamorro, M
700 1 _aRamírez Fernández, J C
700 1 _aSalomon Moh'd, S
700 1 _aLuengo Alpuente, S
700 1 _aResel Estévez, L
773 0 _tArchivos espanoles de urologia
_gvol. 50
_gno. 10
_gp. 1057-66
999 _c9462305
_d9462305